⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
ROSEN, REGARDED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class Action Before October 5, 2026 – Contact Levi & Korsinsky
accessnewswire.com
SPRY
Pomerantz LLP Calls Attention to Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Pomerantz LLP Calls Attention to Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Reminds Investors of October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Alerts Shareholders to Investor Suit Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY Investors Have Rights – If You Lost Money Investing in ARS Pharmaceuticals Inc. Contact Robbins LLP for Information Recovering Your Losses
globenewswire.com
SPRY